Prof. Dr. Wei Lu is a professor of the School of Pharmacy at Fudan University, China. He received his Bachelor of Pharmaceutical Sciences and Ph.D. of Pharmaceutics from Fudan University. Dr. Lu took his post-doctoral training of molecular imaging at the University of Texas M.D. Anderson Cancer, USA. Before joining Fudan, he was appointed as an assistant professor and associate professor (tenured) of College of Pharmacy at the University of Rhode Island, USA. In addition, he is the youth editorial member of Acta Pharmaceutica Sinica B and editorial member of Asian Journal of Pharmaceutical Sciences. Dr. Lu has a multidisciplinary research background in drug delivery and theranostics. His research focuses on development of new formulations for cancer radiotherapy, phototherapy, chemotherapy, immunotherapy as well as vaccine delivery.